Deo; Yashwant M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Deo; Yashwant M..The latest application filed is for "human ctla-4 antibodies and their uses".

Company Profile

1.24.20

Deo; Yashwant M. - Point Vedra Beach FL
Deo; Yashwant M. - East Brunswick NJ
Deo; Yashwant M. - New Brunswick NJ
Deo; Yashwant M. - Annandale NJ
Deo; Yashwant M. - Audubon PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Human Ctla-4 Antibodies And Their Uses App 20190119384 - Korman; Alan J. ; et al.	2019-04-25
Human Ctla-4 Antibodies And Their Uses App 20160257753 - Korman; Alan J. ; et al.	2016-09-08
Molecular Conjugates Comprising Human Monoclonal Antibodies To Dendritic Cells App 20160024192 - DEO; Yashwant M. ; et al.	2016-01-28
Monoclonal antibodies to dendritic cells Grant 9,095,626 - Deo , et al. August 4, 2	2015-08-04
Human Ctla-4 Antibodies And Their Uses App 20140234331 - Korman; Alan J. ; et al.	2014-08-21
Human CTLA-4 antibodies and their uses Grant 8,784,815 - Korman , et al. July 22, 2	2014-07-22
Human CTLA-4 Antibodies And Their Uses App 20130136749 - Korman; Alan J. ; et al.	2013-05-30
Human CTLA-4 antibodies and their uses Grant 8,318,916 - Korman , et al. November 27, 2	2012-11-27
Cell lines and methods for producing proteins Grant 8,222,032 - Parker , et al. July 17, 2	2012-07-17
Molecular Conjugates Comprising Human Monoclonal Antibodies To Dendritic Cells App 20120148596 - DEO; Yashwant M. ; et al.	2012-06-14
Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells Grant 8,142,790 - Deo , et al. March 27, 2	2012-03-27
Methods Of Using Molecular Conjugates Comprising Monoclonal Antibodies To Dendritic Cells App 20120039869 - DEO; Yashwant M. ; et al.	2012-02-16
Human monoclonal antibodies against CD30 Grant 8,088,377 - Keler , et al. January 3, 2	2012-01-03
Human CTLA-4 Antibodies And Their Uses App 20110296546 - Korman; Alan J. ; et al.	2011-12-01
Human CTLA-4 antibodies and their uses Grant 8,017,114 - Korman , et al. September 13, 2	2011-09-13
Human monoclonal antibodies against CD30 App 20100322920 - Keler; Tibor ; et al.	2010-12-23
Human CTLA-4 Antibodies and Their Uses App 20100047244 - Korman; Alan J. ; et al.	2010-02-25
Human CTLA-4 antibodies and their uses Grant 7,605,238 - Korman , et al. October 20, 2	2009-10-20
Cell lines and methods for producing proteins App 20090253176 - Parker; Stephen H. ; et al.	2009-10-08
Human monoclonal antibodies to dendritic cells Grant 7,563,876 - Deo , et al. July 21, 2	2009-07-21
Molecular conjugates comprising human monoclonal antibodies to dendritic cells Grant 7,560,534 - Deo , et al. July 14, 2	2009-07-14
Human monoclonal antibodies against CD30 Grant 7,387,776 - Keler , et al. June 17, 2	2008-06-17
Cells expressing anti-Fc receptor binding components Grant 7,316,812 - Keler , et al. January 8, 2	2008-01-08
Methods of treating disease with glycosylated interferon App 20060159658 - Deo; Yashwant M. ; et al.	2006-07-20
Human CTLA-4 antibodies Grant 6,984,720 - Korman , et al. January 10, 2	2006-01-10
Cells expressing anti-Fc receptor binding components App 20050142120 - Keler, Tibor ; et al.	2005-06-30
Cell lines and methods for producing proteins App 20050090001 - Parker, Stephen H. ; et al.	2005-04-28
Cells expressing anti-Fc receptor binding components Grant 6,682,928 - Keler , et al. January 27, 2	2004-01-27
Human monoclonal antibodies against CD30 App 20040006215 - Keler, Tibor ; et al.	2004-01-08
Human monoclonal antibodies to dendritic cells App 20030167502 - Deo, Yashwant M. ; et al.	2003-09-04
Cells Expressing Anti-fc Receptor Binding Components App 20030039641 - KELER, TIBOR ; et al.	2003-02-27
Human monoclonal antibodies to dendritic cells App 20030031667 - Deo, Yashwant M. ; et al.	2003-02-13
Therapeutic compounds comprised of anti-Fc receptor antibodies Grant 6,410,690 - Deo , et al. June 25, 2	2002-06-25
Therapeutic compounds comprised of anti-Fc receptor antibodies Grant 6,395,272 - Deo , et al. May 28, 2	2002-05-28
Therapeutic compounds comprised of anti-FC receptor binding agents Grant 6,365,161 - Deo , et al. April 2, 2	2002-04-02
Therapeutic Compounds Comprised Of Anti-fc Receptor Antibodies App 20020032312 - DEO, YASHWANT M. ; et al.	2002-03-14
Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies Grant 6,303,755 - Deo , et al. October 16, 2	2001-10-16
Therapeutic multispecific compounds comprised of anti-Fcalpha receptor antibodies App 20010014328 - Deo, Yashwant M. ; et al.	2001-08-16
Therapeutic compounds comprised of anti-Fc receptor antibodies Grant 6,270,765 - Deo , et al. August 7, 2	2001-08-07
Therapeutic multispecific compounds comprised of anti-Fc.alpha. receptor antibodies Grant 6,193,966 - Deo , et al. February 27, 2	2001-02-27
Therapeutic multispecific compounds comprised of anti-Fc.alpha. receptor antibodies Grant 5,922,845 - Deo , et al. July 13, 1	1999-07-13
Therapeutic compounds comprised of anti-Fc receptor antibodies Grant 5,837,243 - Deo , et al. November 17, 1	1998-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.